Share
Title
Code
Session Type
Track
Channel
Date Time
Local Date Time
Moderator:

Short slide overview introductory on current HIV vaccines under investigation by moderator followed by a moderated round-table talk focusing on pros and cons of previous and current HIV vaccines and their implications for future HIV vaccine development including lessons learnt from SARS-CoV-2 vaccine development.

30 min
Live panel discussion
Hanneke SCHUITEMAKER, Janssen Vaccines and Prevention B.V., Netherlands
Pepe ALCAMI, Institute of Health Carlos III, Spain
15 min
Update on the development of Janssen’s prophylactic HIV-1 vaccine candidate
Hanneke SCHUITEMAKER, Janssen Vaccines and Prevention B.V., Netherlands
Hanneke SCHUITEMAKER, Janssen Vaccines and Prevention B.V., Netherlands
15 min
The future of preventive HIV vaccines. Learning from HIV failure and COVID success
Pepe ALCAMI, Institute of Health Carlos III, Spain
Slides